Saturday, March 23, 2013 11:04:51 AM
CAESAREA, Israel – March 10, 2013 – Mazor Robotics Ltd. (TASE: MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, today announced that LifeHealthcare, the Company’s distribution and marketing partner in Australia, has ordered its first Renaissance system. The system will be used for training, marketing, and sales purposes, as the distributor’s sales force penetrates the Australian market. Mazor recently announced on March 3, 2013 that its Renaissance technology received regulatory approval in Australia.
LifeHealthcare is a leading medical devices distributor in Australia and is marketing and distributing the Renaissance technology in the country on behalf of Mazor. The Australian and New Zealand spine market represents a growing market as surgeons and patients seek innovative technology to enhance surgical capabilities and enrich patient care.
“We are very pleased to work with LifeHealthcare to bring Renaissance to Australia,” said Ori Hadomi, CEO of Mazor. “The system sold marks the first Renaissance to be installed in the region and will be used to demonstrate the value it can bring, helping to increase surgeon accuracy and improve patient outcomes. We look forward to introducing more systems to the Australian spinal surgery community as surgeons become accustomed with the technology and its benefits.”
Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
About Mazor
Mazor Robotics (TASE:MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.
U.S. Contacts:
Investors
Aimee Gordon/Robert Jones
EVC Group
646-445-4800
agordon@evcgroup.com/ bjones@evcgroup.com
Media
Chris Gale
EVC Group
646-201-5431
Win a few. Lose a few.
Only the long term counts.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM